TAS-102
CAS No. 733030-01-8
TAS-102 ( TAS102, TAS-102, TAS 102, Trifluridine/tipiracil hydrochloride )
产品货号. M15805 CAS No. 733030-01-8
TAS-102 is an investigational drug candidate for metastatic colorectal Y. It contains trifluridine (TFT) and Tipiracil hydrochloride (TTP) in a molar ratio of 2:1.
纯度: >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥267 | 有现货 |
|
5MG | ¥421 | 有现货 |
|
10MG | ¥721 | 有现货 |
|
25MG | ¥1288 | 有现货 |
|
50MG | ¥2130 | 有现货 |
|
100MG | ¥3216 | 有现货 |
|
200MG | ¥4844 | 有现货 |
|
500MG | ¥7582 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称TAS-102
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述TAS-102 is an investigational drug candidate for metastatic colorectal Y. It contains trifluridine (TFT) and Tipiracil hydrochloride (TTP) in a molar ratio of 2:1.
-
产品描述TAS-102 is an investigational drug candidate for metastatic colorectal Y. It contains trifluridine (TFT) and Tipiracil hydrochloride (TTP) in a molar ratio of 2:1.
-
同义词TAS102, TAS-102, TAS 102, Trifluridine/tipiracil hydrochloride
-
通路Others
-
靶点Other Targets
-
受体Others
-
研究领域——
-
适应症——
化学信息
-
CAS Number733030-01-8
-
分子量575.32
-
分子式C19H23Cl2F3N6O7
-
纯度>98%(HPLC)
-
溶解度Soluble in DMSO
-
SMILESO=C1NC(C(C(F)(F)F)=CN1[C@@H]2O[C@H](CO)[C@@H](O)C2)=O.O=C3NC(C(Cl)=C(CN4C(CCC4)=N)N3)=O.[H]Cl
-
化学全称4-hydroxy-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-(trifluoromethyl)pyrimidin-2(1H)-one compound with 5-chloro-6-((2-iminopyrrolidin-1-yl)methyl)pyrimidine-2,4-diol (1:1) hydrochloride
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Nukatsuka M, et al. anticancer Res. 2015 Sep;35(9):4605-15.
产品手册
关联产品
-
Methyl nomilinate
Methyl nomilinate from citrus can modulate cell cycle regulators to induce cytotoxicity in human colon cancer (SW480) cells in vitro.
-
Arvenin III
Arvenin III is a useful organic compound for research related to life sciences.
-
Quercetin 3-O-(6-gal...
Quercetin 3-O-(6''-galloyl)-beta-D-galactopyranoside can effectively induce apoptosis via p53, MAPKs and the mitochondrial apoptotic pathways.